Cargando…

T212. LEVELS OF GLUTAMATERGIC NEUROMETABOLITES IN PATIENTS WITH SEVERE TREATMENT-RESISTANT SCHIZOPHRENIA: A PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDY

BACKGROUND: Approximately 30% of patients with schizophrenia do not respond to antipsychotics and are thus considered to have treatment-resistant schizophrenia (TRS). To date, only four studies have examined glutamatergic neurometabolite levels using proton magnetic resonance spectroscopy (1H-MRS) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarumi, Ryosuke, Tsugawa, Sakiko, Noda, Yoshihiro, Plitman, Eric, Honda, Shiori, Matshusita, Karin, Chavez, Sofia, Sawada, Kyosuke, Wada, Masataka, Matsui, Mie, Fujii, Shinya, Miyazaki, Takahiro, Chakravarty, Mallar, Uchida, Hiroyuki, Remington, Gary, Graff-Guerrero, Ariel, Mimura, Masaru, Nakajima, Shinichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session III
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234367/ http://dx.doi.org/10.1093/schbul/sbaa029.772

Ejemplares similares

Glutamatergic neurometabolite levels in the caudate are associated with the ability of rhythm production
por: Honda, Shiori, et al.
Publicado: (2023)

Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
por: Moriguchi, Sho, et al.
Publicado: (2018)

Investigating structural subdivisions of the anterior cingulate cortex in schizophrenia, with implications for treatment resistance and glutamatergic levels
por: Ochi, Ryo, et al.
Publicado: (2022)

S16. GLUTAMATERGIC NEUROMETABOLITE LEVELS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA: A CROSS-SECTIONAL 3T PROTON MRS STUDY
por: Iwata, Yusuke, et al.
Publicado: (2018)

Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
por: Goldstein, Meghan Elizabeth, et al.
Publicado: (2015)

Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
por: Itahashi, Takashi, et al.
Publicado: (2021)

Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia
por: Ogyu, Kamiyu, et al.
Publicado: (2020)

Corrigendum to: Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
Publicado: (2023)

Glutamatergic Neurometabolites during Early Abstinence from Chronic Methamphetamine Abuse
por: O’Neill, Joseph, et al.
Publicado: (2015)

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users
por: Tang, Jinsong, et al.
Publicado: (2018)

Resting-State Isolated Effective Connectivity of the Cingulate Cortex as a Neurophysiological Biomarker in Patients with Severe Treatment-Resistant Schizophrenia
por: Wada, Masataka, et al.
Publicado: (2020)

M23. ALTERATION OF REGIONAL CEREBRAL BLOOD FLOW MEASURED BY ARTERIAL SPIN LABELING IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Ogyu, Kamiyu, et al.
Publicado: (2020)

Transcranial magnetic stimulation neurophysiology of patients with major depressive disorder: a systematic review and meta-analysis
por: Kinjo, Megumi, et al.
Publicado: (2021)

T165. ANTI-GLUTAMATERGIC PROPERTY OF N-ACETYLCYSTEINE DOCUMENTED IN VIVO WITH 1H MRS
por: Shungu, Dikoma, et al.
Publicado: (2020)

Reduced signal propagation elicited by frontal transcranial magnetic stimulation is associated with oligodendrocyte abnormalities in treatment-resistant depression
por: Wada, Masataka, et al.
Publicado: (2022)

F178. NEUROANATOMICAL PROFILES OF TREATMENT-RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA
por: Plitman, Eric, et al.
Publicado: (2018)

A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis
por: Cupo, Lani, et al.
Publicado: (2021)

S175. AMOTIVATION IS ASSOCIATED WITH SMALLER VENTRAL STRIATUM VOLUMES IN OLDER PATIENTS WITH SCHIZOPHRENIA
por: Caravaggio, Fernando, et al.
Publicado: (2018)

Cortical thinning in relation to impaired insight into illness in patients with treatment resistant schizophrenia
por: Kim, Julia, et al.
Publicado: (2023)

PT568. Depressive Symptoms and Progressive Hippocampal Volume Atrophy Accelerates the Conversion Process to Dementia from Mild Cognitive Impairment
por: Chung, Jun Ku, et al.
Publicado: (2016)

Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
por: Caravaggio, Fernando, et al.
Publicado: (2018)

T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
por: Uchida, Hiroyuki, et al.
Publicado: (2020)

Relationship Between MR Spectroscopy-Detected Glutamatergic Neurometabolites and Changes in Social Behaviors in a Pilot Open-Label Trial of Memantine for Adults With Autism Spectrum Disorder
por: Nair, Neetu, et al.
Publicado: (2022)

Treatment effects on neurometabolite levels in schizophrenia: A meta-analysis dataset of proton magnetic resonance spectroscopy
por: Kubota, Manabu, et al.
Publicado: (2020)

Motor cortex excitability and inhibitory imbalance in autism spectrum disorder assessed with transcranial magnetic stimulation: a systematic review
por: Masuda, Fumi, et al.
Publicado: (2019)

Abnormal neurometabolites in fibromyalgia patients: Magnetic resonance spectroscopy study
por: Jung, Ye-Ha, et al.
Publicado: (2021)

Neurometabolite alterations in traumatic brain injury and associations with chronic pain
por: Robayo, Linda E., et al.
Publicado: (2023)

T231. QUALITY OF LIFE IN ANTIPSYCHOTIC-NAïVE YOUTH: EXPLORING THE INTERPLAY WITH METABOLIC SIDE-EFFECTS
por: Chintoh, Araba, et al.
Publicado: (2020)

On the Effect of Sex on Prefrontal and Cerebellar Neurometabolites in Healthy Adults: An MRS Study
por: Endres, Dominique, et al.
Publicado: (2016)

Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children
por: Van Dalen, Yvonne W., et al.
Publicado: (2016)

Patterns of functional connectivity alterations induced by alcohol reflect somatostatin interneuron expression in the human cerebral cortex
por: Ochi, Ryo, et al.
Publicado: (2022)

TMS-EEG Research to Elucidate the Pathophysiological Neural Bases in Patients with Schizophrenia: A Systematic Review
por: Li, Xuemei, et al.
Publicado: (2021)

Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson’s Disease
por: Pesch, Beate, et al.
Publicado: (2019)

Dyslexia and age related effects in the neurometabolites concentration in the visual and temporo-parietal cortex
por: Kossowski, Bartosz, et al.
Publicado: (2019)

Interaction of Serum Copper and Neurometabolites on Executive Dysfunction in Unmedicated Patients With Major Depressive Disorder
por: Liao, Xiaoxiao, et al.
Publicado: (2021)

Neurometabolites and sport-related concussion: From acute injury to one year after medical clearance
por: Churchill, Nathan W., et al.
Publicado: (2020)

2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis
por: Quadrelli, Scott, et al.
Publicado: (2019)

Neurometabolite mapping highlights elevated myo-inositol profiles within the developing brain in down syndrome
por: Patkee, Prachi A., et al.
Publicado: (2021)

Erratum to: “Anxiety and neurometabolite levels in the hippocampus and amygdala after prolonged exposure to predator-scent stress”
por: Shevelev, O.B., et al.
Publicado: (2020)

Differences in neurometabolites and transcranial magnetic stimulation motor maps in children with attention-deficit/hyperactivity disorder
por: Kahl, Cynthia K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8na59kne4muikrdgu3f8jnbkfr